Header Logo

Connection

EDWARD MASON to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications EDWARD MASON has written about Cost-Benefit Analysis.
EDWARD MASON
Connection Strength
0.018
Cost-Benefit Analysis
  1. A randomized clinical trial of ampicillin, gentamicin and clindamycin versus cefotaxime and clindamycin in children with ruptured appendicitis. Surg Gynecol Obstet. 1991 May; 172(5):351-6.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.